Welch Daniel G Insider Trades

Insider Trading History

Track insider trading activity for Welch Daniel G. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prothena plc
Prothena plc PRTA
Director
Holding Value $250k 27,000 shares
Last Trade
May 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$264k 27,000 shares
$9.76
$9.25
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $328k 14,058 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$363k 14,058 shares
$25.80
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $943k 40,441 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$200k 7,751 shares
$25.80
$23.31
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $2.02M 51,804 shares
Last Trade
Jun 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 51,804 shares
$22.10
$39.06
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $762k 32,690 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$376k 10,787 shares
$34.84
$23.31
Prothena plc
Prothena plc PRTA
Director
Holding Value $187k 20,183 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 20,183 shares
$6.89
$9.25
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $1.46M 37,500 shares
Last Trade
Jun 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.5M 37,500 shares
$39.96
$39.06
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $628k 26,950 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370k 9,900 shares
$37.42
$23.31
Nuvation Bio
Nuvation Bio NUVB
Director
Holding Value $101k 19,547 shares
Last Trade
May 24, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.03M 659,947 shares
$3.08
$5.17
Nuvation Bio
Nuvation Bio NUVB
Director
Holding Value $3.41M 659,947 shares
Last Trade
May 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.03M 659,947 shares
$3.08
$5.17
Prothena plc
Prothena plc PRTA
Director
Holding Value $139k 15,000 shares
Last Trade
May 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$336k 15,000 shares
$22.39
$9.25
Prothena plc
Prothena plc PRTA
Director
Holding Value $1.22M 132,000 shares
Last Trade
Feb 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.57M 132,000 shares
$27.05
$9.25
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.46M 10,725 shares
$229.00
$228.74
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Dec 14, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$468k 2,044 shares
$228.74
$228.74
Seagen
Seagen SGEN
Director
Holding Value $0 0 shares
Last Trade
Aug 28, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$374k 1,812 shares
$206.26
$228.74
Seagen
Seagen SGEN
Director
Holding Value $2.31M 10,109 shares
Last Trade
Aug 28, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$374k 1,812 shares
$206.26
$228.74
Seagen
Seagen SGEN
Director
Holding Value $2.45M 10,725 shares
Last Trade
Aug 28, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.03M 4,925 shares
$209.08
$228.74
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $8.03M 205,500 shares
Last Trade
Aug 03, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$6.52M 205,500 shares
$31.72
$39.06
Structure Therapeutics
Structure Therapeutics GPCR
Director
Holding Value $30M 768,122 shares
Last Trade
Aug 03, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$13M 411,000 shares
$31.72
$39.06
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $504k 21,605 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$368k 7,110 shares
$51.82
$23.31

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up